Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
962 17 |
Ultima descărcare din IBN: 2024-04-17 22:24 |
Căutarea după subiecte similare conform CZU |
616.5-002.52:616-097 (1) |
Skin. Common integument. Clinical dermatology. Cutaneous complaints (210) |
SM ISO690:2012 VARVARIUC, Viorica, DUTCA, Lucia, GROPPA, Liliana. Afectarea sistemului nervos în lupusul eritematos sistemic. Caz clinic. In: Sănătate Publică, Economie şi Management în Medicină , 2016, nr. 2(66), pp. 110-113. ISSN 1729-8687. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Sănătate Publică, Economie şi Management în Medicină | ||||||
Numărul 2(66) / 2016 / ISSN 1729-8687 /ISSNe 2587-3873 | ||||||
|
||||||
CZU: 616.5-002.52:616-097 | ||||||
Pag. 110-113 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Systemic lupus erythematosus (SLE) is an multisystemic autoimmune disease of connective tissues, which takes many clinical issues. Neurolupus, according to several authors occurs in 25-75% of patients. Neuropsychiatric impairment is considered a negative prognostic factor in SLE and is an important cause of morbidity and mortality. Practically no data specific instrument would characterize the damage of CNS in SLE. In acute damage of CNS and high activity of SLE pulse therapy with immunosuppressive medications is able to induce clinical and laboratory improvement in most of the cases. We report the clinical case of a 36 years old patient with SLE with clinical and paraclinical signs of neuropsychiatric impairment |
||||||
Cuvinte-cheie systemic lupus erythematosus, central nervous system |
||||||
|
DataCite XML Export
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'> <creators> <creator> <creatorName>Varvariuc, V.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Dutca, L.</creatorName> <affiliation>Spitalul Clinic Municipal „Sfânta Treime”, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Groppa, L.G.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> </creators> <titles> <title xml:lang='ro'>Afectarea sistemului nervos în lupusul eritematos sistemic. Caz clinic</title> </titles> <publisher>Instrumentul Bibliometric National</publisher> <publicationYear>2016</publicationYear> <relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1729-8687</relatedIdentifier> <subjects> <subject>systemic lupus erythematosus</subject> <subject>central nervous system</subject> <subject schemeURI='http://udcdata.info/' subjectScheme='UDC'>616.5-002.52:616-097</subject> </subjects> <dates> <date dateType='Issued'>2016-04-30</date> </dates> <resourceType resourceTypeGeneral='Text'>Journal article</resourceType> <descriptions> <description xml:lang='en' descriptionType='Abstract'><p><em>Systemic lupus erythematosus (SLE) is an multisystemic autoimmune disease of connective tissues, which takes many clinical issues. Neurolupus, according to several authors occurs in 25-75% of patients. Neuropsychiatric impairment is considered a negative prognostic factor in SLE and is an important cause of morbidity and mortality. Practically no data specific instrument would characterize the damage of CNS in SLE. In acute damage of CNS and high activity of SLE pulse therapy with immunosuppressive medications is able to induce clinical and laboratory improvement in most of the cases. We report the clinical case of a 36 years old patient with SLE with clinical and paraclinical signs of neuropsychiatric impairment</em></p></description> <description xml:lang='ru' descriptionType='Abstract'><p><em>Системная красная волчанка (СКВ) является аутоиммунным заболеванием соединительной ткани, которая создает много клинических проблем. Нейролюпус по нескольким авторам происходит у 25-75% пациентов. Поражения ЦНС считается отрицательным прогностическим фактором при СКВ, и является важной причиной заболеваемости и смертности у пациентов. Практически нет специфических лабораторных и инструментальных данных, которые могли бы характеризовать повреждения ЦНС при СКВ. При остром поражении ЦНС и высокой активности СКВ, успешно используется иммуносупрессивная пульс терапия, способная индуцировать клиническое и параклиническое улучшение в большинстве случаев. Мы сообщаем о клиническом случае у 36-летней пациентке с СКВ с клиническими и инструментальными признаками психоневрологических нарушений..</em> </p></description> </descriptions> <formats> <format>application/pdf</format> </formats> </resource>